A pair of studies published in the Journal of Psychopharmacology have supported psilocybin’s apparent efficacy in the treatment of cancer-related anxiety and depression.
Based on the results, psilocybin seems to offer immediate and long-lasting positive effects when administered in a controlled setting to a carefully selected population.
TDC page: http://thedrugclassroom.com/video/two-psilocybin-studies-show-efficacy-cancer-related-anxiety-depression/
Psilocybin & psilocin video: https://www.youtube.com/watch?v=4o_hqhp4Yws
Reddit discussion: https://www.reddit.com/r/TheDrugClassroom/comments/5h0t17/psilocybin_for_anxiety_and_depression_what_the/
Participant responses video credit: NYU Langone Medical Center
Donate to The Drug Classroom:
Thank you to my Patreon supporters: Glen Marshall, Jonathon Dunn, Thomas Anaya, Ross Martin, Star Ape, and David Kernell.
Facebook – http://facebook.com/thedrugclassroom
Twitter – http://twitter.com/drugclassroom
The Drug Classroom (TDC) is dedicated to providing the type of drug education everyone should have. Drugs are never going to leave our society and there has never been a society free from drugs.
Therefore, it only makes sense to provide real education free from propaganda.
TDC doesn’t advocate drug use. Rather, we operate with the intention of reducing the harm some substances can bring.
Feel free to ask questions!